Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.

Publikation

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.

Wissenschaftlicher Artikel/Review - 10.02.2022

Yaghi Shadi, Shu Liqi, Bakradze Ekaterina, Omran Setareh Salehi, Argilés Josep M, Amar Jordan, Henninger Nils, Elnazeir Marwa, Liberman Ava, Moncrieffe Khadean, Lu Jenny, Sharma Richa, Cheng Yee, Zubair Adeel S, Simpkins Alexis, Trivioli Giorgio, Kung Justin Chi, Perez Dezaray, Heldner Mirjam R, Scutelnic Adrian, Seiffge David Julian, Siepen Bernhard M, Rothstein Aaron, Khazaal Ossama, Do David, Al Kasab Sami, Rahman Line Abdul, Mistry Eva A, Kerrigan Deborah, Lafever Hayden, Nguyen Thanh N, Klein Piers, Aparicio Hugo J, Frontera Jennifer A, Kuohn Lindsey, Agarwal Shashank, Stretz Christoph, Kala Narendra, ElJamal Sleiman, Chang Alison, Cutting Shawna, Xiao Han, de Havenon Adam, Muddasani Varsha, Wu Teddy, Wilson Duncan, Nouh Amre, Asad Syed Daniyal, Qureshi Abid, Moore Justin, Khatri Pooja, Aziz Yasmin, Casteigne Bryce, Khan Muhib, Cheng Yao, Mac Grory Brian C, Weiss Martin, Ryan Dylan, Vedovati Maria Cristina, Paciaroni Maurizio, Siegler James, Kamen Scott, Yu Siyuan, Leon Guerrero Christopher R, Atallah Eugenie, De Marchis Gian Marco, Brehm Alex, Dittrich Tolga, Psychogios Marios-Nikos, Alvarado-Dyer Ronald, Kass-Hout Tareq, Prabhakaran Shyam, Honda Tristan, Liebeskind David S, Furie Karen

Zitation

Yaghi S, Shu L, Bakradze E, Omran S, Argilés J, Amar J, Henninger N, Elnazeir M, Liberman A, Moncrieffe K, Lu J, Sharma R, Cheng Y, Zubair A, Simpkins A, Trivioli G, Kung J, Perez D, Heldner M, Scutelnic A, Seiffge D, Siepen B, Rothstein A, Khazaal O, Do D, Al Kasab S, Rahman L, Mistry E, Kerrigan D, Lafever H, Nguyen T, Klein P, Aparicio H, Frontera J, Kuohn L, Agarwal S, Stretz C, Kala N, ElJamal S, Chang A, Cutting S, Xiao H, de Havenon A, Muddasani V, Wu T, Wilson D, Nouh A, Asad S, Qureshi A, Moore J, Khatri P, Aziz Y, Casteigne B, Khan M, Cheng Y, Mac Grory B, Weiss M, Ryan D, Vedovati M, Paciaroni M, Siegler J, Kamen S, Yu S, Leon Guerrero C, Atallah E, De Marchis G, Brehm A, Dittrich T, Psychogios M, Alvarado-Dyer R, Kass-Hout T, Prabhakaran S, Honda T, Liebeskind D, Furie K. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke 2022; 53:728-738.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Stroke 2022; 53

Veröffentlichungsdatum

10.02.2022

eISSN (Online)

1524-4628

Seiten

728-738

Kurzbeschreibung/Zielsetzung

A small randomized controlled trial suggested that dabigatran may be as effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to compare direct oral anticoagulants (DOACs) to warfarin in a real-world CVT cohort.